Discover

BNTX
BioNTech SE
93.92
2 x 66.71
1 x 100.00
bid
ask
+
0.87
0.93%
2 @ 06:58 AM
94.22 +0.30 (0.32%)
Ytd-1.34%
1y-12.64%
92.56
day range
94.00
79.52
52 week range
124.00
Open93.07Prev Close93.05Low92.56High94.00Mkt Cap23.75B
Vol530.08KAvg Vol950.81KEPS-5.78P/EN/AForward P/E-18.58
Beta1.32Short Ratio2.50Inst. Own20.19%DividendN/ADiv YieldN/A
Ex Div Date06-02Earning08-0450-d Avg93.65200-d Avg99.111yr Est121.52

BNTX News

benzinga.com
'BioNTech Investor Förtsch Says Founders' Spinout Raises Concerns' - Bloomberg News

https://www.bloomberg.com/news/articles/2026-06-17/biontech-investor-fortsch-says-founders-spinout-r

benzinga.com
UBS Upgrades BioNTech to Buy, Raises Price Target to $135

UBS analyst David Dai upgrades BioNTech (NASDAQ:BNTX) from Neutral to Buy and raises the price ta

benzinga.com
Bernstein Initiates Coverage On BioNTech with Market Perform Rating, Announces Price Target of $96

Bernstein analyst Jeffrey Walch initiates coverage on BioNTech (NASDAQ:BNTX) with a Market Perfor

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Canaccord Genuity Maintains Buy on BioNTech, Lowers Price Target to $158

Canaccord Genuity analyst John Newman maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the

benzinga.com
Wells Fargo Maintains Overweight on BioNTech, Lowers Price Target to $140

Wells Fargo analyst Mohit Bansal maintains BioNTech (NASDAQ:BNTX) with a Overweight and lowers th

benzinga.com
'F.D.A. Blocked Publication of Research Finding Covid and Shingles Vaccines Were Safe' - The New Yor

https://www.nytimes.com/2026/05/05/us/politics/fda-covid-vaccine-studies.html

BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape
benzinga.com
BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape

BioNTech shares fall after Q1 revenue miss and wider net loss, despite lower-than-expected loss and

Earnings Scheduled For May 5, 2026
benzinga.com
Earnings Scheduled For May 5, 2026

benzinga.com
BioNTech Affirms FY2026 Sales Guidance of $2.328B-$2.678B vs $2.560B Est

BioNTech (NASDAQ:BNTX) affirms FY2026 sales outlook from $2.328 billion-$2.678 billion to $2.328 bil

benzinga.com
BioNTech Q1 Adj. EPS $(2.28) Beats $(2.52) Estimate, Sales $138.000M Miss $214.620M Estimate

BioNTech (NASDAQ:BNTX) reported quarterly losses of $(2.28) per share which beat the analyst consens

SanDisk, Western Digital, Clorox And Other Big Stocks Moving Lower In Friday's Pre-Market Session
benzinga.com
SanDisk, Western Digital, Clorox And Other Big Stocks Moving Lower In Friday's Pre-Market Session

US stock futures mixed, SanDisk (NASDAQ: SNDK) shares drop 5.6% in pre-market following strong Q3 re

benzinga.com
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $130 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and mai

Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'
benzinga.com
Elon Musk Questions COVID-19 Vaccine Dosage, Says It Was 'Obviously Too High'

Elon Musk raises concerns over COVID-19 vaccine dosage, citing a severe reaction that nearly led to

benzinga.com
Reported Saturday, BioNTech And DualityBio's Trastuzumab Pamirtecan Meets Primary Endpoint With 47.9

Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary ef

Why Is Pfizer Stock Dropping Tuesday?
benzinga.com
Why Is Pfizer Stock Dropping Tuesday?

Pfizer Inc (NYSE:PFE) shares are trading lower on Tuesday after the company and its COVID-19 vaccine

Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat
benzinga.com
Pfizer, BioNTech Hit Pause On COVID Shot Trial As Enrollment Falls Flat

Pfizer & BioNTech halt recruitment for a major U.S. COVID vaccine trial for adults 50–64 due to

benzinga.com
'Pfizer And Partner BioNTech Say They Will Stop U.S. Covid-19 Vaccine Study In Healthy Adults Ages 5

Vaccine makers Pfizer PFE.N and BioNTech 22UAy.DE have halted recruitment for a large U.S. trial of

benzinga.com
HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $130

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowe

benzinga.com
BioNTech To Present Data From Diversified Portfolio In Field Of Lung Cancer At European Lung Cancer

Presentations showcase progress in BioNTech's late-stage lung cancer programs, reinforcing the p

benzinga.com
Morgan Stanley Maintains Overweight on BioNTech, Lowers Price Target to $125

Morgan Stanley analyst Terence Flynn maintains BioNTech (NASDAQ:BNTX) with a Overweight and lower

benzinga.com
Citigroup Maintains Buy on BioNTech, Lowers Price Target to $130

Citigroup analyst Geoff Meacham maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price

BioNTech Analysts Slash Their Forecasts After Q4 Earnings
benzinga.com
BioNTech Analysts Slash Their Forecasts After Q4 Earnings

BioNTech (BNTX) reported upbeat Q4 results and FY26 sales guidance below estimates. Shares gained 7.

benzinga.com
TD Cowen Maintains Hold on BioNTech, Lowers Price Target to $94

TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:BNTX) with a Hold and lowers the price t

Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving High

Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected

benzinga.com
BMO Capital Maintains Outperform on BioNTech, Lowers Price Target to $128

BMO Capital analyst Etzer Darout maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers th

benzinga.com
Jefferies Maintains Buy on BioNTech, Lowers Price Target to $138

Jefferies analyst Akash Tewari maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price t

BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls
benzinga.com
BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls

BioNTech stock tumbled Tuesday as investors digested new questions. Here's what execs said on th

8 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
8 Health Care Stocks With Whale Alerts In Today's Session

Dow Jumps Over 300 Points; Kohl's Posts Upbeat Earnings
benzinga.com
Dow Jumps Over 300 Points; Kohl's Posts Upbeat Earnings

US stocks rise with Dow up over 300 points, S&P 500 and NASDAQ also gaining. Kohl's Corp sha

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

US Stocks Mixed; United Natural Foods Shares Fall After Q2 Results
benzinga.com
US Stocks Mixed; United Natural Foods Shares Fall After Q2 Results

US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilit

BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
benzinga.com
BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture

BioNTech stock falls in premarket trading after co-founders announce plans to launch a new mRNA vent

FreightCar America Posts Downbeat Q4 Results, Joins BioNTech, PROG Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
benzinga.com
FreightCar America Posts Downbeat Q4 Results, Joins BioNTech, PROG Holdings And Other Big Stocks Mov

US stock futures lower, FreightCar America (RAIL) plunges after weak earnings. Other stocks moving l

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Earnings Scheduled For March 10, 2026
benzinga.com
Earnings Scheduled For March 10, 2026

benzinga.com
BioNTech Q4 EPS $(0.38) Beats $(0.47) Estimate, Sales $1.056B Beat $889.480M Estimate

BioNTech (NASDAQ:BNTX) reported quarterly losses of $(0.38) per share which beat the analyst consens

BioNTech: Q4 Earnings Insights
benzinga.com
BioNTech: Q4 Earnings Insights

benzinga.com
BioNTech And Co-Founders Plan To Pursue Next-Gen mRNA Innovations In Co-Founders-Led New Company; Ex

BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanni

Oracle, Ulta, Adobe, More Stocks With Earnings This Week
benzinga.com
Oracle, Ulta, Adobe, More Stocks With Earnings This Week

Investors are anticipating earnings releases from Oracle, Ulta, Adobe, Dick's, AeroVironment and

A Preview Of BioNTech's Earnings
benzinga.com
A Preview Of BioNTech's Earnings

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars
benzinga.com
Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor c

Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?
benzinga.com
Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb

Ten large-cap stocks led last week's gains, driven by upbeat earnings, guidance, buybacks, and k

Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot
benzinga.com
Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot

BioNTech has sued Moderna, alleging its mNEXSPIKE vaccine uses patented COVID vaccine technology wit

This Rocket Lab Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
benzinga.com
This Rocket Lab Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Earnings Scheduled For November 3, 2025
benzinga.com
Earnings Scheduled For November 3, 2025

Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): Are The Others In Your Portfolio?
benzinga.com
Synopsys, Chewy, And The Trade Desk Are Among Top 10 Large Cap Losers Last Week (Sep. 8- Sep. 12): A

Earnings misses, weak guidance, and downgrades drove large-cap decliners—led by Synopsys, Chewy, and

Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday
benzinga.com
Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday

benzinga.com
Earnings Scheduled For August 4, 2025

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
benzinga.com
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficienc

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the